Literature DB >> 8963199

Newly licensed drugs.

R E Ferner.   

Abstract

Mesh：

Year:  1996        PMID： 8963199      PMCID： PMC2352471          DOI： 10.1136/bmj.313.7066.1157

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Storage and disposal of embryos and gametes.

Authors:  A Trounson; K Dawson
Journal:  BMJ       Date:  1996-07-06

2.  Drug trials in epilepsy.

Authors:  G Mignot
Journal:  BMJ       Date:  1996-11-09

3.  Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.

Authors:  M C Walker; L M Li; J W Sander
Journal:  BMJ       Date:  1996-11-09

4.  Growth in the use of antibiotics in the community in England and Scotland in 1980-93.

Authors:  P G Davey; R P Bax; J Newey; D Reeves; D Rutherford; R Slack; R E Warren; B Watt; J Wilson
Journal:  BMJ       Date:  1996-03-09

5.  Health care: what's science got to do with it?

Authors:  M Peckham; R Smith
Journal:  BMJ       Date:  1995-01-28

6.  Probability of adverse events that have not yet occurred: a statistical reminder.

Authors:  E Eypasch; R Lefering; C K Kum; H Troidl
Journal:  BMJ       Date:  1995-09-02

7.  Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population.

Authors:  P D Pharoah; W Hollingworth
Journal:  BMJ       Date:  1996-06-08

8.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

9.  Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994.

Authors:  M D Rawlins
Journal:  J R Coll Physicians Lond       Date:  1995 Jan-Feb
  9 in total
  11 in total

1.  Prescribing new drugs: qualitative study of influences on consultants and general practitioners.

Authors:  M I Jones; S M Greenfield; C P Bradley
Journal:  BMJ       Date:  2001-08-18

2.  The quantity and quality of clinical practice guidelines for the management of depression in primary care in the UK.

Authors:  P Littlejohns; F Cluzeau; R Bale; J Grimshaw; G Feder; S Moran
Journal:  Br J Gen Pract       Date:  1999-03       Impact factor: 5.386

3.  The need for pharmacoeconomic evaluations in the NHS.

Authors:  J P Griffin
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

4.  Failures of the therapeutic chain as a cause of drug ineffectiveness.

Authors:  Albert Figueras; Joan-Ramon Laporte
Journal:  BMJ       Date:  2003-04-26

5.  The influence of big pharma.

Authors:  R E Ferner
Journal:  BMJ       Date:  2005-04-16

Review 6.  How NICE may be outflanked.

Authors:  R E Ferner; Sarah E McDowell
Journal:  BMJ       Date:  2006-05-27

7.  Health technology assessment--the role of the pharmaceutical panel.

Authors:  T Walley; M Rawlins; K Stein
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

Review 8.  Drug safety assessment in clinical trials: methodological challenges and opportunities.

Authors:  Sonal Singh; Yoon K Loke
Journal:  Trials       Date:  2012-08-20       Impact factor: 2.279

9.  Antibiotics and allergic disorders in childhood.

Authors:  Sue Jordan; Mel Storey; Gareth Morgan
Journal:  Open Nurs J       Date:  2008-05-22

Review 10.  Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials.

Authors:  T Isomura; S Suzuki; H Origasa; A Hosono; M Suzuki; T Sawada; S Terao; Y Muto; T Koga
Journal:  Eur J Clin Nutr       Date:  2016-05-18       Impact factor: 4.016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.